Abba Medix Group Inc. is traded on the CSE (Canadian Stock Exchange) under the symbol, ABA.

Through the pending RedeCan acquisition, Abba will be a Health Canada licensed producer of medical marijuana. As such, we are committed to medicinal marijuana research and regulatory compliance.

Abba’s purpose is to lead in bringing credibility, dignity, legitimacy, and overall, positive change to the medical marijuana industry; its perception amongst medical professionals, investors, the public, and government; and most importantly, to those who consume it.

In one word: elevate.

Our goal is to be more than a producer of the best medical cannabis. We intend to be a great company, setting higher standards as a leading and lasting contributor to this rapidly growing, and important industry.